Corporate
Oct. 9, 2014
Allergan seeks to block Pershing Square from voting in buyout row
The Irvine-based drugmaker filed a motion for preliminary injunction asking a Santa Ana federal court judge to block the hedge fund from voting out board members in an upcoming shareholder meeting.
Daily Journal Staff Writer
Allergan Inc. filed a motion for preliminary injunction in Santa Ana federal court overnight Monday asking U.S. District Judge David O. Carter to enjoin the company's largest shareholder, the hedge fund Pershing Square Capital Management LP, from voting its 9.7 percent stake in an upcoming shareholder meeting.
The meeting, scheduled for Dec. 18, is expected to result in the ouster of six Aller...
For only $95 a month (the price of 2 article purchases)
Receive unlimited article access and full access to our archives,
Daily Appellate Report, award winning columns, and our
Verdicts and Settlements.
Or
$895, but save $100 when you subscribe today… Just $795 for the first year!
Or access this article for $45
(Purchase provides 7-day access to this article. Printing, posting or downloading is not allowed.)
Already a subscriber?
Sign In